Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Cancer Letters|September 7, 2014
Loss-of-function RNAi screens in breast cancer cells identify AURKB, PLK1, PIK3R1, MAPK12, PRKD2, and PTK6 as sensitizing targets of rapamycin activityOliver Ou, Konrad Huppi, Sirisha Chakka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2020
Transcriptional Subtypes Resolve Tumor Heterogeneity and Identify Vulnerabilities to MEK Inhibition in Lung AdenocarcinomaAnneleen Daemen, Jonathan E Cooper, Szymon Myrta, et al.
Molecular Cancer Therapeutics|March 5, 2020
CDK9 Blockade Exploits Context-dependent Transcriptional Changes to Improve Activity and Limit Toxicity of Mithramycin for Ewing SarcomaGuillermo Flores, Joel H Everett, Elissa A Boguslawski, et al.
Cancer Cell|October 10, 2018
Pharmacological Induction of RAS-GTP Confers RAF Inhibitor Sensitivity in KRAS Mutant TumorsIvana Yen, Frances Shanahan, Mark Merchant, et al.
Cancer Discovery|November 19, 2020
Machine-Learning and Chemicogenomics Approach Defines and Predicts Cross-Talk of Hippo and MAPK PathwaysTrang H Pham, Thijs J Hagenbeek, Ho-June Lee, et al.
Cancer Research Communications|October 11, 2024
Functional RNAi Screening Identifies G2/M and Kinetochore Components as Modulators of TNFα/NF-κB Prosurvival Signaling in Head and Neck Squamous Cell CarcinomaEthan L Morgan, Anthony D Saleh, Shaleeka Cornelius, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 11, 2020
Enhanced Protein Damage Clearance Induces Broad Drug Resistance in Multitype of Cancers Revealed by an Evolution Drug-Resistant Model and Genome-Wide siRNA ScreeningFangyuan Shao, Xueying Lyu, Kai Miao, et al.
Cell Reports|January 19, 2016
Functional Genomic Screening Reveals Splicing of the EWS-FLI1 Fusion Transcript as a Vulnerability in Ewing SarcomaPatrick J Grohar, Suntae Kim, Guillermo O Rangel Rivera, et al.
Nature Communications|August 9, 2016
Synthetic viability by BRCA2 and PARP1/ARTD1 deficienciesXia Ding, Arnab Ray Chaudhuri, Elsa Callen, et al.
Molecular Cancer Therapeutics|November 8, 2006
Asparagine synthetase as a causal, predictive biomarker for L-asparaginase activity in ovarian cancer cellsPhilip L Lorenzi, William C Reinhold, Martina Rudelius, et al.
Pageof 9